Laurus Labs Ltd. (LAURUSLABS)
BSE
Closed
Oct 9, 2026
Day's Range
1,988.6052 wk Range
843.30Overview - LAURUSLABS - Laurus Labs Ltd.
Key Statistics
Valuation
Enterprise Value
1.09T
P/E (Trailing)
‪98.02‬
P/E (Forward)
‪67.63‬
PEG Ratio
‪1.72‬
Price / Sales (TTM)
‪14.78‬
Price / Book
‪20.25‬
EV / EBITDA
‪53.85‬
Profitability
Gross Margin
‪62.69%‬
Profit Margin
‪15.04%‬
Operating Margin
‪25.38%‬
Return on Assets
‪8.45%‬
Return on Equity
‪16.36%‬
Ownership
Shares Outstanding
540.31M
Float
363.42M
Held by Insiders
‪32.03%‬
Held by Institutions
‪33.35%‬
Price stats
Beta
‪0.36‬
50-Day Avg
‪1,873.55‬
200-Day Avg
‪1,357.10‬
Dividends
Payout Ratio
‪9.89%‬
Frequency
Semi-Annual
Analyst Consensus
14 analysts
Average price target
‪₹ 1,561.38‬Market Cap - LAURUSLABS - Laurus Labs Ltd.
Peers - LAURUSLABS - Laurus Labs Ltd.
Peer Comparison
Compared with companies in Drug Manufacturers - Specialty & Generic listed on BSE.
- LAURUSLABSBSELaurus Labs Ltd.1.07TMarket Cap+56.59%52-week change98.03P/E (Trailing)‪15.04%‬Profit Margin
- DIVISLABBSEDivi's Laboratories Ltd.2.47TMarket Cap+29.72%52-week change84.62P/E (Trailing)‪26.04%‬Profit Margin
- CIPLABSECipla Ltd.1.05TMarket Cap-20.00%52-week change23.19P/E (Trailing)‪16.25%‬Profit Margin
- DRREDDYBSEDr. Reddy's Laboratories Ltd.1.00TMarket Cap-2.69%52-week change17.73P/E (Trailing)‪16.36%‬Profit Margin
- AUROPHARMABSEAurobindo Pharma Ltd.980.78BMarket Cap+32.58%52-week change27.88P/E (Trailing)‪10.52%‬Profit Margin
- MANKINDBSEMankind Pharma Ltd.978.50BMarket Cap-3.07%52-week change47.92P/E (Trailing)‪13.85%‬Profit Margin
- LUPINBSELupin Ltd.895.65BMarket Cap-0.53%52-week change20.77P/E (Trailing)‪17.47%‬Profit Margin
Profile Summary - LAURUSLABS - Laurus Labs Ltd.
About
Laurus Labs Ltd. is a prominent entity within the pharmaceutical industry, primarily engaged in the research, development, and manufacturing of active pharmaceutical ingredients (APIs), finished dosage forms (FDFs), and synthesis services. As a key player in the healthcare sector, Laurus Labs focuses on delivering…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
